The role of MRI in pharmacovigilance of natalizumab-treated MS patients: a "Known unknown"?

Beschreibung

Auslieferung: Mike P. Wattjes, Seckbruch 3, 30916 Isernhagen, E-Mail: MikePWattjes@gmx.de

Autor*in

Mike P Wattjes

Themen in »The role of MRI in pharmacovigilance of natalizumab-treated MS patients: a "Known unknown"?«

Brain MRI Multiple Sclerosis Pharmacovigilance

Stimmen zu »The role of MRI in pharmacovigilance of natalizumab-treated MS patients: a "Known unknown"?«

Details

Link teilen